NOVN.CH

105.76

+1.19%↑

LONN.CH

549.8

+1.03%↑

SDZ.CH

46.56

+2.74%↑

STMN.CH

88.76

+1.23%↑

BANB.CH

59

+1.29%↑

NOVN.CH

105.76

+1.19%↑

LONN.CH

549.8

+1.03%↑

SDZ.CH

46.56

+2.74%↑

STMN.CH

88.76

+1.23%↑

BANB.CH

59

+1.29%↑

NOVN.CH

105.76

+1.19%↑

LONN.CH

549.8

+1.03%↑

SDZ.CH

46.56

+2.74%↑

STMN.CH

88.76

+1.23%↑

BANB.CH

59

+1.29%↑

NOVN.CH

105.76

+1.19%↑

LONN.CH

549.8

+1.03%↑

SDZ.CH

46.56

+2.74%↑

STMN.CH

88.76

+1.23%↑

BANB.CH

59

+1.29%↑

NOVN.CH

105.76

+1.19%↑

LONN.CH

549.8

+1.03%↑

SDZ.CH

46.56

+2.74%↑

STMN.CH

88.76

+1.23%↑

BANB.CH

59

+1.29%↑

Search

Roche Holding AG

Open

SectorGezondheidszorg

302.4 0.87

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

297.2

Max

303.2

Belangrijke statistieken

By Trading Economics

Inkomsten

1.7B

3.7B

Verkoop

-15B

16B

K/W

Sectorgemiddelde

22.865

35.739

Dividendrendement

3.62

Winstmarge

23.266

Werknemers

103,249

EBITDA

547M

6.5B

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.62%

3.08%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-368M

205B

Vorige openingsprijs

301.53

Vorige sluitingsprijs

302.4

Nieuwssentiment

By Acuity

50%

50%

149 / 371 Rangschikking in Healthcare

Roche Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 okt 2025, 08:54 UTC

Belangrijke Marktbewegers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

18 sep 2025, 14:01 UTC

Acquisities, Fusies, Overnames

Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion -- 2nd Update

18 sep 2025, 10:05 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

89bio Shares Soar Premarket on Takeover by Roche

18 sep 2025, 10:04 UTC

Acquisities, Fusies, Overnames

Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion -- Update

18 sep 2025, 05:37 UTC

Acquisities, Fusies, Overnames

Roche to Buy 89bio for Up to $3.5 Billion

24 jul 2025, 15:09 UTC

Winsten

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24 jul 2025, 05:36 UTC

Winsten

Roche Backs 2025 Views After Strong Sales of Key Drugs

1 okt 2025, 20:33 UTC

Acquisities, Fusies, Overnames

Roche Begins Tender Offer for 89bio Pursuant to Previously Announced Merger Agreement

1 okt 2025, 09:05 UTC

Populaire aandelen

Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental -- WSJ

18 sep 2025, 14:12 UTC

Acquisities, Fusies, Overnames

89bio Stock Soars 86%. Why Roche Is Buying the Biopharma Company for $3.5 Billion. -- Barrons.com

18 sep 2025, 07:37 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Roche's 89bio Acquisition Gives Its Drug Pipeline Potential Blockbuster -- Market Talk

18 sep 2025, 05:09 UTC

Acquisities, Fusies, Overnames

89bio Says Deal Reflects Potential of Pegozafermin Drug Candidate

18 sep 2025, 05:06 UTC

Acquisities, Fusies, Overnames

Roche: Deal Is Expected to Close in 4Q

18 sep 2025, 05:06 UTC

Acquisities, Fusies, Overnames

Roche: Deal Enhanc Portfolio in Cardiovascular, Renal, Metabolic Diseases

18 sep 2025, 05:05 UTC

Acquisities, Fusies, Overnames

Roche: MASH Is One of Most Prevalent Comorbidities of Obesity

18 sep 2025, 05:05 UTC

Acquisities, Fusies, Overnames

Roche: 89bio Developing Potential Treatment for Metabolic Dysfunction-Associated Steatohepatitis

18 sep 2025, 05:04 UTC

Acquisities, Fusies, Overnames

Roche to Buy 89bio for $14.50 a Share in Cash, Contingent Value Right of Up to $6 a Share

18 sep 2025, 05:03 UTC

Acquisities, Fusies, Overnames

Roche: Total Deal Value Is Up to $3.5B

18 sep 2025, 05:02 UTC

Acquisities, Fusies, Overnames

Roche to Buy 89bio

18 sep 2025, 05:02 UTC

Acquisities, Fusies, Overnames

Roche Enters Into Deal to Buy 89bio

8 aug 2025, 10:51 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8 aug 2025, 07:39 UTC

Marktinformatie
Winsten

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5 aug 2025, 10:40 UTC

Marktinformatie

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24 jul 2025, 06:52 UTC

Marktinformatie
Winsten

Roche Looks Confident in a Tricky Environment -- Market Talk

24 jul 2025, 05:05 UTC

Winsten

Roche Backs 2025 View

24 jul 2025, 05:05 UTC

Winsten

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24 jul 2025, 05:04 UTC

Winsten

Correct: Roche 1H Sales Rose 4% On Year , Reported

24 jul 2025, 05:04 UTC

Winsten

Roche 1H Net Pft Was Seen at CHF8.4B

24 jul 2025, 05:04 UTC

Winsten

Roche 1H Net Pft CHF7.8B

24 jul 2025, 05:03 UTC

Winsten

Roche 1H Oper Pft CHF12.0B

Peer Vergelijking

Prijswijziging

Roche Holding AG Prognose

Sentiment

By Acuity

149 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
help-icon Live chat